external quality assurance services (chimera eqas) r

EXTERNAL QUALITY ASSURANCE SERVICES (Chimera EQAS) R

User Manual

EQAS LAB

External Quality Assurance Service

(Histocompatibility & Immunophenotyping)

Page 1 of 34 Issue Date: 12/02/2021

Contents

1. Introduction

2. Contact Information

3. Why Choose Us

4. Accreditation and Recognition

5. Confidentiality and Privacy Policy

6. Data Security

7. Participation

7.1.Eligibility for Participation

7.2.Terms and Conditions

7.3.Registration Process

8. Schemes Offered

9. Program and Specimen Identifier

10. EQAS Sample

10.1.Sample Type and Source

10.2.Sample Preparation and Distribution

10.3.Sample Handling and Processing

10.4.Safety Precautions

11. Request

11.1.Request for Repeat Sample

11.2.Request for Extension of the Result Submission Deadline

12. Result Evaluation

12.1.Criteria for Result Evaluation and Interpretation

12.2.Scoring Strategy

12.3.Result Interpretation

12.4.Performance Summary

12.5.Program Summary

13. Complaint and Appeal

14. Subcontracted Activities




15. Website know-how

15.1.Accessing Website

15.2.Password

15.3.Notification

15.4.Amending Registration

15.5.Add/ Remove Scheme

15.6.Annual Renewal

16. Reference Materials

17. Result and Submission

17.1.Result Submission

17.2.Other Submissions

17.3.Feedback

18. Cost of Participation

19. References




1. Introduction

The Chimera® External Quality Assurance Service has been initiated by Chimera

Translational Research Fraternity Pvt. Ltd (http://translational.in/). The program is

specially designed for the laboratories involved in Flow Cytometry, Molecular and

Histocompatibility Testing. This program is the first of its kind Indian program, launched

to address the unmet need of an EQAS in this arena.

The program is designed as per the IS0/IEC 17043:2010 guidelines for Conformity

Assessment- General Requirements for Proficiency Testing. Each aspect of the program

is brainstormed and coordinated with a group of domestic as well as global experts.

This program is intended to unify the diagnostics laboratories and improve quality in the

diagnostics services in the niche area.

This Manual contains all the information you will need to participate effectively in

Chimera® EQAS. The web portal of Chimera® EQAS helps the user to manage their EQA

scheme participation. This includes: Managing and controlling their registration details,

Viewing fees and invoices, result entry, access to test specific worksheet and instructions,

performance reports and overall program summary.

The Chimera EQAS website provides detailed and up-to-date information about the

program, as well as the route for data entry and retrieval. The website provides service

updates, closing date reminders and links to other related organisations or sources of

information.

a. Aim

We aim to empower the participants to compare results, analyse performance, fine-tune

execution and contribute towards the accuracy of the nationwide flow cytometry,

molecular and transplant laboratory services.

Note: All the above functions are available to a laboratory who has confirmed their

participation in the program.

http://translational.in/




b. Objective:

Our objective is to ensure the smooth and efficient operation of the program as described

below, in compliance with ISO/IEC 17043:2010 for the following:

● Foster confidence

● Ensure access to a panel of domain experts

● Streamline information access and exchange via an all accessible portal

● Employ sophisticated infrastructure to assure quality

2. Address and Host Organization

Chimera® External Quality Assurance Service is operated by Chimera Translational

Research Fraternity Pvt. Ltd. The Scheme has dedicated secure office, laboratory and

logistics facilities.

Chimera External Quality Assurance Services

(Chimera Translational Research Fraternity Pvt. Ltd.)

209C, 2nd and 3rd Floor Masjid Moth South Extension Part-II, New Delhi

Pin- 110049,

Phone No: - +91-9811014986

Email Id: - [email protected]

Opening Hours: 8:00 am to 6:00 pm Monday to Saturday (IST)

3. Why Choose Us

We are a group of Pathologists, Flow Cytometrists, Immunologists, Biotechnologists and

Data Scientists who are passionate about quality improvement in diagnostic laboratories.

We tirelessly work towards the betterment of the program. We provide a platform to you

Note: Please quote your laboratory code number/ Name in all communications related

to the program. If the response is not received within 5 working days, please contact

again as the email communication may have been lost.

mailto:[email protected]




for reviewing your activities, interacting with your peers & domain experts, and

contributing to a healthy and reliable diagnostic ecosystem. We make sure that:

Your Samples are fit-for-purpose: We are creating a sample library to store the samples

to ensure that the provided sample is suitable for participating laboratories. Our technical

team is working continuously on the improvement of the sample library.

Customized and affordable pricing: Calculate your own cost of participation by using

our online cost calculator.

Work in your peer group: Work in a peer-group, identify the group biased error and

check their performance with the laboratories over the world.

Expert Remarks: Receive detailed analysis reports of your performance, curated by top

domain experts.

4. Accreditation and Recognition

Accreditation: Chimera® External Quality Assurance service is accredited by NABL as

per the requirements of ISO/IEC 17043:2010 – Conformity Assessment – General

requirements for proficiency testing. The scope of accreditation can also be viewed on the

NABL website (https://nabl-india.org/proficiency-testing-provider/pt-providersprogram/).

https://nabl-india.org/proficiency-testing-provider/pt-providersprogram/




Figure 1: Certificate of Accreditation

5. Confidentiality

Chimera® ensures the utmost security of its information. Registration information, raw

data and performance details are confidential between the individual participants, we

make sure that any participant related information has limited access, even within our

team. All the information is password protected and can be accessed only by authorized

personnel. Performance reports are only shared with the respective participants via the

password-protected dashboard.

Additionally, upon registration, each participating laboratory is assigned a random alpha-

numeric code to maintain confidentiality. Exchange of information between us and the

participants is solely tagged and identified by the assigned code.




Performance data may be shared with regulatory and/or accreditation bodies where

appropriate and necessary, but only after receiving explicit written permission from the

participant. Chimera® takes the permission of sharing the data with these bodies at the

time of registration.

The assigned codes mapping is managed by the data manager with strict access control.

All the participants are also requested to keep their results and performance reports

confidential and refrain from comparing results amongst themselves. Failure to do so may

result in termination of participation in the Chimera® EQAS

6. Data Security

Chimera® takes every possible measure to maintain the utmost security of data received

from the participants. We collect test results, raw data of the tests, organization details,

contact details, complaints and feedback from the participants. To protect all the data we

use the following security measures and technologies:

● Physical access controls, including secured premises to prevent unauthorized

persons from gaining access to Personal Information.

● System access controls to prevent unauthorized access and use of Personal

Information, which vary based on the nature of information processing.

● Data access controls to ensure Personal Information is accessible and

manageable only by properly authorized associates.

● Transmission controls and other controls to ensure that Personal Information

cannot be read, copied, modified or removed without authorization during

electronic transmission or transport.

● Input controls to ensure that any Personal Information is provided and edited

by participants or by us as per their direction.

● Data backups are taken regularly and are secured and encrypted.




● If Chimera® is the source of a breach; we will contact the participant and

describe the breach, along with Chimera® mitigation actions. Where

applicable, we will provide appropriate identity theft prevention and

mitigation services at no cost to the affected person for not less than 12

months.

7. Participation

Participation in External Quality Assurance Program is intended to achieve inter-

laboratory and, if possible, inter-instrument harmonisation of results, and to monitor the

general level of performance in a laboratory. This assessment is long-term, retrospective

and provides periodic assessments of how the laboratory performs. Participation in EQAS

is entirely voluntary. A nationally available program, such as Chimera® EQAS, allows

participating laboratories to compare and improve the results within their peer group.

7.1.Eligibility for Participation:

Chimera® EQAS is primarily designed for the diagnostics laboratories either accredited or

planning to get accreditation. Participation is open to all diagnostics laboratories working

in Transplant Immunology and Haematology. All the manufacturers of diagnostics kits

and reagents having the testing facilities are also encouraged to participate.

Participants are advised to review the terms and conditions before registration. We will

help you if you have any queries about the suitability of any particular survey for your

needs.

7.2.Terms and Condition:

The terms and conditions for participation are available on the registration page

(https://s3.ap-south-

1.amazonaws.com/translational.in/Chimerapt/15+NDA+from+PArticipants.pdf). We request

Note: Despite our efforts, no security measure can be absolute, and there can be no

guarantee that the Personal Information will not be accessed through malicious means,

inadvertent disclosure, or mistake.

https://s3.ap-south-1.amazonaws.com/translational.in/Chimerapt/15+NDA+from+PArticipants.pdf

https://s3.ap-south-1.amazonaws.com/translational.in/Chimerapt/15+NDA+from+PArticipants.pdf




you to go through the terms and conditions for participation in Chimera EQAS

thoroughly at the time of registration. Acceptance of terms and conditions confirms your

approval to abide by it throughout your participation in the program.

7.3.Registration Process:

Registrations for the new participants are open year-round. For registration, the

participant has to fill and submit the online registration form available in the login

(http://eqas.in/dashboard/login/ ) section of the portal.

Completion of the registration form indicates that the prospective participant agrees to

abide by the terms and conditions of registration with the programme.

Participants must provide the following details at the time of registration:

General Information: Create your laboratory user name and password. Fill the

complete address of the laboratory along with postal code where the sample will be sent.

Contact Information: Name and contact details (E-Mail Id, Phone Number) of the

laboratory head and point of contact from the laboratory.

Note: The contact details provided will be used to send email instructions, links for a

password reset, sample dispatch details, upcoming round information and other

information/announcement related to the program.

http://eqas.in/dashboard/login/




Figure 2: Overview of Registration Page

Scheme Registration: Select the scheme as per your laboratory requirement in the

registration page. Upon completion of the complete form click on the submit button.

Upon completion of successful payment, a unique code will be assigned for your

laboratory, which will be further used for communication.

8. Schemes Offered

Chimera External Quality Assurance Service offers different tests under the

Transplant Immunology and Immunophenotyping arenas. We offer a flexible range of

General

Information

Contact

Information

Scheme

Registration




schemes in which a participant can select the test combination as per their laboratory

requirement. The entire scheme offered is qualitative and simultaneous in nature.

a. Histocompatibility and Transplant Immunology: This scheme is useful for the

laboratories working in Transplant Immunology.

● HLA Typing [A, B & DR] (HT-01)

● PRA Screening [Class-I & II] (HID-01)

● CDC Cross Match (XM-01)

● Flow Cytometry Cross Match (XM-02)

b. Immunophenotyping: The program is offered for the laboratory performing flow

cytometer based identification of leukaemia and lymphoma.

● Leukaemia and Lymphoma Diagnosis (IPT-01)

c. Serology

• SARS-CoV-2 Antibody Testing

d. Haematology

• Complete Blood Count

Scope of the Services: The entire scope listed here is accredited by National Accreditation

Board for Testing and Calibration Laboratories (NABL) as per ISO/IEC 17043:2010. All the

samples are dispatched at 2-8O C. For detailed sample handling instruction visit the resource

section. To check the scheduled dates of sample dispatch kindly refer the calendar available

on the website. The entire tests included in the scope are qualitative in nature.

S.No. Test Name & Code Sample

Type

Frequency Sample/

Round

Sample

Volume

1 HLA Typing [A, B &

DR] (HT-01)

Whole Blood 3 times a

year

1 1.5 ml

2 Luminex PRA

Screening [Class-I &

II] (HID-01)

Serum 3 times a

year

1 0.5 ml

3 CDC- Cross Match

(XM-01)

Buffy Coat

and Serum

3 times a

year

1

8 and 0.5 ml

4 Flow-Cytometry Cross

Match (XM-02)




5 Immunophenotyping

[Leukaemia &

Lymphoma] (IPT-01)

Whole Blood

and blood

smear

3 times a

year

1 1.0 ml

6 SARS-CoV-2 Serology

Testing

Serum 3 times a

year

7 0.5 ml

7 Complete Blood Count Whole Blood 3 times a

year

1 1 ml

9. Programme and specimen identifiers

Each round of the annual cycle is identified by a code which includes the following:

● Test Category

● Round Number

● Year

Each test in the scope is identified by a two-letter code. The codes for the different scheme

are mentioned above in the program details section. Each specimen is given an alphanumeric

code comprising the following information:

● Test code

● Round number

● Last two digits of the year

10. EQAS Sample

10.1. Sample Type and Source

Survey specimens are obtained from a variety of sources and are designed to be as

close to patients’ clinical material as possible. The samples used in the entire scheme

are of human origin, which represents the samples of regular diagnostic practice. The

samples for each test are procured from the reference laboratory. Samples provided to

Chimera External Quality Assurance Service

Sample ID: HT-01/012021

Sample Type: Whole Blood

Date: 13/02/2021




the participants mostly include whole blood, serum and buffy coat. The sample

volume and specification along with the frequency is mentioned in section 11 of this

manual.

Figure 3: EQAS Samples

10.2. Sample Preparation and Distribution:

The sample(s) used in EQA is sufficiently stable and homogenous. To ensure the stability

of the sample it is tested multiple times for the analytes.

After ensuring the Homogeneity and Stability, the samples are packed as per the IATA

packaging guidelines. Transportation of the sample is carried out at an ambient

temperature (2-8℃) is ensured by packaging sample(s) with multiple cool packs.

Packaged samples are dispatched to each participant.




The Distribution Schedule for all schemes is available on the Chimera® EQAS website in

the Calendar available in the Resources section.

Figure 4: Calendar Option

Once the specimens have been despatched, a personalised communication is sent, along with

the package and tracking details. If for any reason specimens are not received, not received

when expected, or are damaged upon receipt, notify the Chimera® EQAS Team.

Figure 5: Sample Dispatch Communication

Expected Arrival of sample in laboratory

Tracking Details




10.3. Sample Handling and Processing:

Kindly follow the below-mentioned instruction for handling and processing the samples:

● Upon receipt of the samples, visit the Chimera® EQAS Web Portal and fill in

the sample receiving details in the given format.

Figure 6: Sample Receiving Confirmation

● The sample will be transported at ambient temperature (2-8O C) and it is

recommended to perform the test within the below-mentioned timeline:

S.No Test Name Timeline

1. HLA Typing [A,B,DR] 7 days (3)

2. Luminex PRA Screening [Class I & II] 7 days

3. CDC-XM 24 hours

4. FCXM 24 hours

5. Immunophenotyping [Leukaemia &

Lymphoma]

24 hours

6. SARS-CoV-2 Serology testing 7 days

7. Haematology 24 hours

Submit the Sample

Confirmation




● The sample must be stored in the refrigerator under sterile conditions immediately

after receiving in order to prevent contamination.

● If required, perform the viability test to check the viability of sample upon receiving,

by using your own standardized method of testing.

● For Immunophenotyping: Kindly check the microscopic slide image updated on the

portal in the resource section to decide the panel of antibodies to put up the test.

● Perform the test according to your validated protocol.

● Kindly maintain the record of sample receiving date, time and temperature upon

which the sample was received along with the sample processing date in the

worksheet provided on the website.

● Results have to be analyzed as per the standard of the participating lab.

11. Requests

11.1. Request for Repeat Sample:

Once the sample has been dispatched from our facilities we share a mail to our

participants with tracking ID and expected time for sample receiving. If the participant

receives damage and/or contaminated samples, they are advised to intimate us via

mail/call. The following remedial actions will be taken :

S.

No

Sample Type Remedial Action

1. HLA Typing [A, B &

DR]

Participants are requested to intimate us within 48 hours of

receiving the sample. A fresh sample will be provided to

them and the deadline is extended for 2 days.

Note: The last date/time to process the sample will be considered from the date/time

of sample receiving.




2. PRA Screening

[Class I & II]


receiving the sample. A fresh sample will provided to them

and the deadline is extended for 2 days.

3. CDC Crossmatch Extra sample(s) will not be provided to the participants.

Participant(s) are requested to participate in the subsequent

round. 4. Flow Cytometry

Crossmatch

5. Immunophenotyping

[Leukemia &

Lymphoma]

Extra sample(s) will not be provided to the participants.


round.

6. SARS-CoV-2

Serology Testing


receiving the sample. A fresh sample will be provided to

them and the deadline is extended for 2 days.

7. Haematology Testing Extra sample(s) will not be provided to the participants.


round.

11.2. Request for Extension of the result submission deadline

The deadline for result submission is communicated in the mail sent after sample

dispatch, which is 15 days after the sample receiving. After 15 days the portal would not

allow to submit the result.

Chimera reserves all the rights for extension of result submission deadline. Please write to

us for further information.

Note: In case more than 30 % participant is facing similar issue the round is called off

and all the participants are informed at priority. Also, the participants are informed

about the supplementary rounds.




Figure 7: Result Submission Page

12. Result Evaluation

All the reports provided in this program are comprehensive, elaborated and clear. The

report includes all the numerical data and graphs to facilitate the understanding of the

report. The reports are generated within 15 days of the end of the result submission

deadline. The report is identified with a unique code given to the participating

laboratory. The participant can download their report form result and submission section

by logging into their account.

12.1. Criteria for Result Evaluation and Interpretation:

All the results submitted by the participants are evaluated in the following manner:

The tests offered in Chimera EQAS are qualitative and no statistical calculation is

applicable hence the results received from the participants are evaluated as per the result

evaluation criteria given in the ISO/IEC 13528:2015 guidelines. The assigned value for

the proficiency testing sample is determined by the result reported by the reference

laboratory.




12.2. Scoring Strategy:

Measurements of performance are based on deviations of results from the assigned

values provided by the reference laboratory. The report provided to each participant

includes the performance score. The score is assigned in the following manner:

● The final result submitted by participant laboratory is evaluated against the

assigned value provided by the reference laboratory.

● Based on the comparison, the participant laboratory is assigned a

performance score of acceptable and unacceptable.

12.3.Result Interpretation:

Acceptable: Results concordant with Assigned Value

Unacceptable: Results discordant with Assigned Value

12.4.Performance Summary: Along with the report, Chimera® also provides the

performance summary. This summary is available in the result section of your

account. This section will reflect the overall performance of your laboratory over

the round. The performance summary and score is visible in the main dashboard of

your account and is not visible to other participants.

Figure 8: Performance Summary

Performance

Summary




13. Complaint and Appeal

We welcome the opportunity to discuss any problem or query concerning Chimera®

EQAS. Participants concerned about the quality of the specimens received are

encouraged to take photographs of the specimens in question, wherever possible, and

to send these with their query.

Upon receiving a complaint, we make every effort to resolve it within 10 working

days. If the complaint is not resolved to the participant’s satisfaction, it will be

discussed with the advisory board to resolve it to the level of satisfaction.

The participant may also appeal against a performance assessment score. The appeal

will be dealt with in the same timeframe as a complaint.

While an appeal is in progress, no further action on performance will be taken,

although it will continue to be monitored. If the participant remains dissatisfied with

the outcome of the appeal, the final decision and resolution depends on the advisory

committee report.

14. Subcontracted Activities

The Chimera® EQAS program has been designed and developed in coordination with

Chimera Transplant Research Foundation, a stand-alone transplant laboratory which

is ISO 15189:2012 accredited.

It is responsible for the following activities:

● Sample Procurement

● Sample Sourcing

● Sample Testing and Characterization

● Homogeneity and Stability Testing

● Technical Advisory




15. Website Know-How

15.1. Accessing the Website: To begin with, kindly follow the below-mentioned

steps:

● Search for (http://eqas.in/ ) in Google to launch the Chimera® EQAS Website.

Figure 9: Website Landing Page

● Go to the login page and enter your user name and password.

Website address

Note: If your laboratory is not yet a participant of Chimera EQAS follow the

registration process (section 7(c)).

http://eqas.in/




Figure 10: Login Page

15.2. Password

The portal allows you to change and retrieve your forgotten password:

a. Forgotten Password: If you have forgotten your password, please use the ‘Forgot

Password’ link available on the website.

● Click on forgot password link on the login page.

● It will directs to another page where you have to submit the registered e-mail

id.

● Fill the registered e-mail Id.

Within 1 minute you will receive an e-mail from [email protected] with a subject

name Password Reset with the link for the password reset. This link of the email will

take you to the portal where you can create a new password for your account.





Figure 11: Password Reset Page

Registered email Id

Click here




15.3. Notification: Chimera® will send the prior notifications related to on-going rounds

and schemes via mail. All the notifications can also be accessed from the homepage of

your dashboard. The notification will be reflected on the right top corner of the home

page. Following categories of notifications will be available on the portal:

● Upcoming Distribution: This notification reflects upcoming rounds for

your laboratory.

● Active result submission: Active rounds for which users can enter

results.

● Result Submissions Closed: It represents that results are being analysed

by Chimera® and it is no longer possible to submit or edit results

● Reports Published: This indicates that the round is completed. The

report of the individual laboratory is available.

● Invoice and Payment Status: The pending invoice and payment status

will be also reflected in the notification bar.

15.4. Amending Registration: For the addition or removal of any test in the scope other

than those selected at the time of registration, or changing contact details provided at the

time of registration, you are requested to reach out to us via mail. The changes and

amendments will be incorporated from the next round.

15.5. Annual Renewal: For annual renewal of your subscription kindly write to us

[email protected].

16. Reference Materials

Sample-specific case studies, test-specific worksheets as well as instructions are provided

for the ease of the participants. All the reference materials can be accessed on our portal

from the ‘Reference Material’ section. Following are the steps for downloading the

reference materials:

a. Case Studies: With every sample, we provide a case study. The sample-specific

case studies can be accessed in the following manner:

● Go to the ‘Reference Materials’ section.





● Click on ‘Case Studies’ and select the scope of the program.

● It will direct to the case study page.

● You can access the round wise case studies from this section.

Figure 12: Reference Materials (case study)

b. Test Specific Worksheets and Instructions: to download test specific worksheet

follow the below mention steps:

● Go to the ‘Reference Materials’ section.

● Click on the ‘Reference Manual’ section and select the scope of the program.

● It will direct you to reference manual page.

● You can access the worksheet of all the tests from this section.

Click here to

download

case study




Figure 13: Reference Materials (Instruction & Worksheets)

17. Results and Submissions

The result submission page can be accessed from the ‘Submit Now’ section of the

website.

17.1. Results Submission: The portal provides facilities to submit the results of

various schemes. The portal is also designed in a way that it will allow you to see

your previous results. For result, submissions go to the ‘Submit Now’ section of the

portal. A specific format is available for each test in the scope.

● Select ‘Submit Now’ from the navigation bar.

● Click on the ‘Test Category’ for which you have to submit the result.

Click here to

download

test specific

instruction




Figure 14: Result submission Page

A. General Information: In this section, you have to submit the general

information about the sample, including

● Sample ID

● Laboratory ID

● Sample receiving date & time

● Sample processing date & time

● Number of samples received

After completing all the fields click on the submit button to successfully submit

the data.

Result Submission Page

Note: To submit the result you will be initially taken through the general information page

followed by test specific result submission page.




Figure 15: Result Submission (General Information)

B. Test result: To submit the result select the test name for which you have to

submit your results.

● It will direct you to another page where you have to fill all the information

and result.

● After filling all the details click on the submit page.

● After successful completion of your result, a summary of the result will be

created.

Submit the general

information (Sample

Specific)




Figure 16: Result Submission (HLA Typing)

C. View/ Save/ Print the submitted result: The submitted result from the

laboratory is compiled at one place. You can view a non-editable copy of your

submitted result. To see the submitted result:

a. Go to the ‘Result and Submission’ section.

b. Select ‘Previous Submission’

c. Select the test category.

d. You find a table of your submitted result.

e. You can print or download the result in PDF format.

Result submission

form (HLA Typing)

Note: If you find any transcription error in the submitted result, you can resubmit the

results. The last submitted result will be used for evaluation.




Figure 17: Previous Submission Page

17.2. Other Submission: The portal also provides you facilities to submit the

information like sample receiving, query, feedback, appeal. All the services are

accessible after logging into your respective account.

a. Query: If you have any query you can write to us on [email protected] or you can

submit your query by filling the query form available in the FAQs section of the

portal. Logging into your account is not required for this feature; it can be accessed

from the FAQ section of the website.

Click here to see

submitted result





Figure 18: Query Page

b. Sample Receiving: Participants have to submit the sample details upon sample

receipt. The functionality is available when the round is active. This can be done by

logging in to your account that is registered in Chimera® EQAS.

c. Feedback: In the Chimera® EQAS, we seek feedback from the participants for the

overall experience with the program and round. To submit the feedback a form is

available in the Result and Submission section of the portal. You can submit the

feedback by filling the form. Your feedback helps us in improving our program and is

thus of utmost importance to us.




Figure 19: Feedback Page

d. Appeal: A separate form for appeal is available on the portal. You can file appeals,

using this platform at any given time. The following information is requested for

recording an appeal from the participants:

● Date and time

● Name and designation of person registering the appeal

● Name of organization.

● Appeal

● Additional remarks

Submit your valuable

feedback here.




Figure 20: Appeal Page

18. Cost of Participation

Annual participation charges are based on the total on-ground cost of providing EQAS.

Figure 21: Price Calculator




The annual participation charge depends on the number of tests and number of years for

which you have participated. The participants can calculate their personalized cost of

participation by using the online available algorithm.

Figure 22: Performa Invoice

19. References

1. ISO-IEC 17043: 2010 Conformity Requirements for Proficiency Testing

assessment General International Organization for Standardization, 2010.

2. NABL-181 Specific Criteria for PT Provider Accreditation.

3. Permenter, J., Ishwar, A., Rounsavall, A., Smith, M., Faske, J., Sailey, C. J., &

Alfaro, M. P. (2015). Quantitative analysis of genomic DNA degradation in whole

blood under various storage conditions for molecular diagnostic testing. Molecular

and cellular probes, 29(6), 449-453.

external quality assurance services (chimera eqas) r

Documents